Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00206856 · ClinicalTrials.gov registry record · Phase 4
Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)
A Phase 4 study, sponsored by Abbott RDx Cardiometabolic.
- Terminated
- Registry status
- Phase 4
- Development phase
- 720
- Enrollment target
NCT00206856 is a Phase 4 study that was terminated before completion, run by Abbott RDx Cardiometabolic. The registered enrollment target is 720 participants.
The verdict
NCT00206856, a Phase 4 study, was terminated before completion, sponsored by Abbott RDx Cardiometabolic.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 720 participants
- Enrollment target
Study Summary
To determine the clinical utility of using the Triage® BNP Test to guide therapy in outpatients with heart failure
Interventions
- DEVICE Triage® B-Type Natriuretic Peptide (BNP) Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 720 participants |
| Start Date | 2003-07 |
| Est. Completion | 2006-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00206856
The ClinicalTrials.gov registry entry for NCT00206856 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 720 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott RDx Cardiometabolic, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Triage® B-Type Natriuretic Peptide (BNP) Test is the first listed.
NCT00206856 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00206856 about?
NCT00206856 is a clinical study titled "Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)". To determine the clinical utility of using the Triage® BNP Test to guide therapy in outpatients with heart failure
What is the current status of trial NCT00206856?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 720 participants. The study started on 2003-07. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00206856?
The interventions under investigation include: Triage® B-Type Natriuretic Peptide (BNP) Test (DEVICE).
Who is sponsoring clinical trial NCT00206856?
This trial is sponsored by Abbott RDx Cardiometabolic, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.